Stereotaxic Instruments Market - Size, Share, Outlook, and Forecast till 2026

Stereotaxic instruments are apparatus attached to the head to precisely localize an area in the brain by means of coordinates related to its intracerebral structures. These instruments are designed for minimally invasive forms of surgical interventions such as ablation, biopsy, lesion, and radiosurgery. These are used for application in animals and humans diagnosed with malignant, benign and functional indications in the brain and spine, including primary and secondary tumors. Some examples of stereotaxic Instruments are smart bregmafinder, parallel rail bases, and motorized manipulator arms.
The use of stereotaxic instruments in the treatment of Parkinson disease (PD) through stereotactic surgery has eliminated long term complications of levodopa- an earlier treatment used against PD such as mood and cognitive impairment and dyskinesia. Such new approaches have boosted growth of stereotaxic instruments market.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/197670

Stereotaxic instruments are used in breast cancer bioscopy. According to the report by Centers for Disease Control and Prevention, in 2018, around 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S. along with 63,960 new cases of non-invasive breast cancer. Such increasing incidences of breast cancer are expected to propel demand for stereotaxic instruments for breast cancer biopsies, which in turn are driving growth of the stereotaxic instruments market.

Several animal research studies use stereotaxic instruments to target specific sites of the brain and to induce pharmacological agents cross the blood–brain barrier. In rodents these instruments introduce fluids directly to the brain or to an implant. These research studies help to understand the effects of various drugs and vaccines before they are used on humans. Such vast range of experiments need extensive use of these instruments, which in turn is expected to boost the growth of stereotaxic instruments market.

However, these instruments have a certain risks such as bleeding of tumor and brain. Bleeding might result into mild headache or a stroke and in extreme conditions can lead to coma or even death. Infections and seizures are also observed at the site of the surgery due to these instruments, which may restrain growth of the stereotaxic instruments market.

Get Best Discount On This Report: https://www.worldwidemarketreports.com/discount/197670

Key Developments for Stereotaxic Instruments Market

Researchers from Quethera, a gene therapy firm in Cambridge revealed in the online journal Cambridge Independent on September 21, 2017, that the brain bioscopy using stereotaxic instruments could stop glaucoma and Alzheimer’s disease. The new CRISPR-based therapeutics to the brain utilizes stereotaxic technique to cure various types of cancers and malaria. Key players operating in stereotaxic instruments market include Stoelting Co, Braintree Scientific, Inc, David Kopf Instruments, Neurostar, and Leica Biosystems.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

This release was published on openPR.